Two new biotech companies based on world-leading regenerative medicine expertise in Edinburgh, Scotland, and backed by rival healthcare venture firms, have been launched this week.
The first of these is Resolution Therapeutics, which is focused on developing macrophage cell therapy to help regenerate the liver in patients with end stage liver disease. It was launched on 14 September with a £26
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?